123 related articles for article (PubMed ID: 32816795)
41. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
[TBL] [Abstract][Full Text] [Related]
42. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials.
Stoodley RG; Aaron SD; Dales RE
Ann Emerg Med; 1999 Jul; 34(1):8-18. PubMed ID: 10381989
[TBL] [Abstract][Full Text] [Related]
43. Are beta2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review.
Smucny JJ; Flynn CA; Becker LA; Glazier RH
J Fam Pract; 2001 Nov; 50(11):945-51. PubMed ID: 11711010
[TBL] [Abstract][Full Text] [Related]
44. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
45. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
Griffiths B; Ducharme FM
Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
[TBL] [Abstract][Full Text] [Related]
46. Interventions for promoting habitual exercise in people living with and beyond cancer.
Bourke L; Homer KE; Thaha MA; Steed L; Rosario DJ; Robb KA; Saxton JM; Taylor SJ
Cochrane Database Syst Rev; 2013 Sep; (9):CD010192. PubMed ID: 24065550
[TBL] [Abstract][Full Text] [Related]
47. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.
Cates CJ; Crilly JA; Rowe BH
Cochrane Database Syst Rev; 2006 Apr; (2):CD000052. PubMed ID: 16625527
[TBL] [Abstract][Full Text] [Related]
48. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
Ducharme FM; Hicks GC
Cochrane Database Syst Rev; 2000; (3):CD002314. PubMed ID: 10908555
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials.
Milanović Z; Sporiš G; Weston M
Sports Med; 2015 Oct; 45(10):1469-81. PubMed ID: 26243014
[TBL] [Abstract][Full Text] [Related]
50. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Sovani MP; Whale CI; Tattersfield AE
Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
[TBL] [Abstract][Full Text] [Related]
51. Stepping down the dose of inhaled corticosteroids for adults with asthma.
Crossingham I; Evans DJ; Halcovitch NR; Marsden PA
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011802. PubMed ID: 28146601
[TBL] [Abstract][Full Text] [Related]
52. Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables.
Bizjak DA; Nussbaumer D; Winkert K; Treff G; Takabajashi K; Mentz L; Schober F; Buhl JL; John L; Dreyhaupt J; Steeb L; Harps LC; Parr MK; Diel P; Zügel M; Steinacker JM
Sports Med Open; 2023 Aug; 9(1):79. PubMed ID: 37640958
[TBL] [Abstract][Full Text] [Related]
53. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Appleton S; Smith B; Veale A; Bara A
Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
[TBL] [Abstract][Full Text] [Related]
54. Beta2-agonists for acute bronchitis.
Becker LA; Hom J; Villasis-Keever M; van der Wouden JC
Cochrane Database Syst Rev; 2011 Jul; (7):CD001726. PubMed ID: 21735384
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE
Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916
[TBL] [Abstract][Full Text] [Related]
56. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.
Salpeter SR; Buckley NS; Salpeter EE
J Gen Intern Med; 2006 Oct; 21(10):1011-9. PubMed ID: 16970553
[TBL] [Abstract][Full Text] [Related]
57. Polarized vs. Threshold Training Intensity Distribution on Endurance Sport Performance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Rosenblat MA; Perrotta AS; Vicenzino B
J Strength Cond Res; 2019 Dec; 33(12):3491-3500. PubMed ID: 29863593
[TBL] [Abstract][Full Text] [Related]
58. Heliox-driven β2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis.
Rodrigo GJ; Castro-Rodriguez JA
Ann Allergy Asthma Immunol; 2014 Jan; 112(1):29-34. PubMed ID: 24331390
[TBL] [Abstract][Full Text] [Related]
59. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis.
Amegadzie JE; Gorgui J; Acheampong L; Gamble JM; Farrell J; Gao Z
J Asthma; 2021 Mar; 58(3):344-359. PubMed ID: 31668101
[TBL] [Abstract][Full Text] [Related]
60. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
